SCHEMBL6215340

SCHEMBL6215340

CN(C)/C=C/c1nc2ccc(F)cc2c(=O)n1-c1ccccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6215343 1.00
SCHEMBL6217516 0.87
SCHEMBL6217521 0.87
SCHEMBL6217686 0.87 LMNA (0.66)
SCHEMBL6217688 0.87 LMNA (0.66)
SCHEMBL6216766 0.84
SCHEMBL8300710 0.84 TP53 (0.63)
SCHEMBL8300712 0.84 TP53 (0.63)
SCHEMBL6220435 0.83 TDO2 (0.46)
SCHEMBL6602443 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0884310-B1 Quinazolin-4-one ampa antagonists PFIZER PROD INC (US) 2005-09-07 EP disclosed
US-6921764-B2 Thieno-pyrimidin-4-one AMPA antagonists PFIZER INC. (US) 2005-07-26 US disclosed
US-20040049039-A1 Quinazolin-4-one ampa antagonists PFIZER INC 2004-03-11 US disclosed
US-6627755-B1 Neurodegenerative, psychological, and nervous system disorder; drug abuse, alcoholism PFIZER INC 2003-09-30 US disclosed
EP-0884310-A1 Quinazolin-4-one ampa antagonists Pfizer Products Inc. (US) 1998-12-16 EP disclosed